SCHEDULE 13D/A

LENZ THERAPEUTICS INC

Common Stock, par value $0.00001 per share · CUSIP: 52635N103

Event date: 2025-06-10

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Versant Venture Capital VI, L.P.Reported CIK 0001687880

  Shares: 2,101,199 · Class: 7.5%

• Versant Ventures VI GP, L.P.Reported CIK 0001777654

  Shares: 2,101,199 · Class: 7.5%

• Versant Ventures VI GP-GP, LLCReported CIK 0001777652

  Shares: 2,101,199 · Class: 7.5%

• Versant Vantage II, L.P.Reported CIK 0001832235

  Shares: 842,162 · Class: 3%

• Versant Vantage II GP, L.P.Reported CIK 0001839790

  Shares: 842,162 · Class: 3%

• Versant Vantage II GP-GP, LLCReported CIK 0001839789

  Shares: 842,162 · Class: 3%

• Versant Venture Capital VII, L.P.Reported CIK 0001750266

  Shares: 1,319,323 · Class: 4.7%

• Versant Ventures VII GP, L.P.Reported CIK 0001777655

  Shares: 1,319,323 · Class: 4.7%

• Versant Ventures VII GP-GP, LLCReported CIK 0001777656

  Shares: 1,319,323 · Class: 4.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.